InspireMD Statistics
Total Valuation
InspireMD has a market cap or net worth of $83.31 million. The enterprise value is $28.04 million.
Important Dates
The last earnings date was Wednesday, March 18, 2026, before market open.
| Earnings Date | Mar 18, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
InspireMD has 46.80 million shares outstanding. The number of shares has increased by 53.42% in one year.
| Current Share Class | 43.53M |
| Shares Outstanding | 46.80M |
| Shares Change (YoY) | +53.42% |
| Shares Change (QoQ) | +12.12% |
| Owned by Insiders (%) | 17.12% |
| Owned by Institutions (%) | 19.89% |
| Float | 19.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.91 |
| Forward PS | 5.29 |
| PB Ratio | 1.35 |
| P/TBV Ratio | 1.45 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.12 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.74, with a Debt / Equity ratio of 0.04.
| Current Ratio | 5.74 |
| Quick Ratio | 5.30 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -106.88% and return on invested capital (ROIC) is -64.70%.
| Return on Equity (ROE) | -106.88% |
| Return on Assets (ROA) | -53.37% |
| Return on Invested Capital (ROIC) | -64.70% |
| Return on Capital Employed (ROCE) | -84.53% |
| Weighted Average Cost of Capital (WACC) | 9.13% |
| Revenue Per Employee | $136,045 |
| Profits Per Employee | -$739,182 |
| Employee Count | 66 |
| Asset Turnover | 0.15 |
| Inventory Turnover | 2.12 |
Taxes
In the past 12 months, InspireMD has paid $63,000 in taxes.
| Income Tax | 63,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.93% in the last 52 weeks. The beta is 0.93, so InspireMD's price volatility has been similar to the market average.
| Beta (5Y) | 0.93 |
| 52-Week Price Change | -33.93% |
| 50-Day Moving Average | 1.70 |
| 200-Day Moving Average | 2.12 |
| Relative Strength Index (RSI) | 60.80 |
| Average Volume (20 Days) | 43,154 |
Short Selling Information
The latest short interest is 31,585, so 0.07% of the outstanding shares have been sold short.
| Short Interest | 31,585 |
| Short Previous Month | 37,577 |
| Short % of Shares Out | 0.07% |
| Short % of Float | 0.16% |
| Short Ratio (days to cover) | 1.69 |
Income Statement
In the last 12 months, InspireMD had revenue of $8.98 million and -$48.79 million in losses. Loss per share was -$0.76.
| Revenue | 8.98M |
| Gross Profit | 2.65M |
| Operating Income | -49.61M |
| Pretax Income | -48.72M |
| Net Income | -48.79M |
| EBITDA | -49.17M |
| EBIT | -49.61M |
| Loss Per Share | -$0.76 |
Full Income StatementBalance Sheet
The company has $54.21 million in cash and $2.22 million in debt, with a net cash position of $51.99 million or $1.11 per share.
| Cash & Cash Equivalents | 54.21M |
| Total Debt | 2.22M |
| Net Cash | 51.99M |
| Net Cash Per Share | $1.11 |
| Equity (Book Value) | 55.20M |
| Book Value Per Share | 1.27 |
| Working Capital | 50.76M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 444,000 |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | 29.50% |
| Operating Margin | -552.56% |
| Pretax Margin | -542.63% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
InspireMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -53.42% |
| Shareholder Yield | -53.42% |
| Earnings Yield | -60.96% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for InspireMD is $4.00, which is 124.72% higher than the current price. The consensus rating is "Buy".
| Price Target | $4.00 |
| Price Target Difference | 124.72% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 27, 2021. It was a reverse split with a ratio of 1:15.
| Last Split Date | Apr 27, 2021 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |
